Mycobacterium fortuitum peritonitis in two patients receiving continuous ambulatory peritoneal dialysis

American Journal of Nephrology

Volumn 19, Issue 5, 1999, Pages 586-589

  Vera, Gilberto ^a   Lew, Susie Q ^a,b  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Mycobacterium fortuitum; Nontuberculous mycobacterium; Peritoneal dialysis; Peritonitis

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; COTRIMOXAZOLE; TOBRAMYCIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PERITONITIS; CASE REPORT; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MALE; MYCOBACTERIUM FORTUITUM; ORAL DRUG ADMINISTRATION; PERITONEAL FLUID; PRIORITY JOURNAL; RISK FACTOR;

EID: 0032704571     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013524     Document Type: Article

References (18)

1. Keane WF, Alexander SR, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, Huang CC, Kawaguchi Y, Piraino B, Riella M, Schaefer F, Vas S: Peritoneal dialysis-related peritonitis treatment recommendations 1996 Update. Perit Dial Int 1996;16:557-573.
2. Pulliam JP, Vernon DD, Alexander SR, Hartstein AI, Golper TA: Nontuberculous mycobacterial peritonitis associated with continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1983;2:610-614.
3. Wood GL, Hall GS, Schreiber MJ: Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis. J Clin Microbiol 1986;23:786-788.
4. LaRocco MT, Mortensen JE, Robinson A: Mycobacterium fortuitum peritonitis in a patient undergoing chronic peritoneal dialysis. Diagn Microbiol Infect Dis 1986;4:161-164.
5. Soriano F, Rodriguez-Tudela JL, Gomez-Garces JL, Velo M: Two possibly related cases of Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis 1989;8: 895-897.
6. Dunmire RB III, Breyer JA: Nontuberculous Mycobacterial peritonitis during continuous ambulatory peritoneal dialysis: Case report and review of diagnostic and therapeutic strategies. Am J Kidney Dis 1991; 18(1): 126-130.
7. Kolmos HJ, Brahm M, Bruun B: Peritonitis with Mycobacterium fortuitum in a patient on continuous ambulatory peritoneal dialysis. Scand J Infect Dis 1992;24:801-803.
8. Hakim A, Hisam N, Reuman PD: Environmental Mycobacterial peritonitis complicating peritoneal dialysis: Three cases and review. Clin Infect Dis 1993; 16:426-431.
9. Choi CW, Cha DR, Kwon YJ, Cho WY, Pyo HJ, Kim HK: Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis. Korean J Intern Med 1993; 8:25-27.
10. White R, Abreo K, Flanagan R, Gadallah M, Krane K, El-Shahawy M, Shakamuri S, McCoy R: Nontuberculous Mycobacterial infections in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1993;22(4):581-587.
11. Wallace RJ Jr, Swenson JM, Silcox VA, Good RS, Tschen JA, Stone MS: Spectrum of disease due to rapidly growing Mycobacteria. Rev Infect Dis 1983;5:657-679.
12. Hand WL, Sanford JP: Mycobacterium fortuitum - A human pathogen. Ann Intern Med 1970;73:971-979.
13. Golper T, Churchill D, Burkart J, Firanek C. Geary D, Gotch F, Moore L, Nolph K, Powe N, Singh H, Teehan B, Tsamaloukas A, Warady B: NKF-DOQI Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis 1997;30:S67-S103.
14. Swenson JM, Wallace RJ Jr, Silcox VA, Thornsberry C: Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother 1985;28:807-811.
15. Wallace RJ Jr, Swenson JM, Silcox VA, Bullen MG: Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis 1985;152:500-513.
16. Brown BA, Wallace RJ Jr, Onyi GO, De Rosas V, Wallace RJ: Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother 1992;36:180-184.
17. Tartaglione T: Treatment of nontuberculous mycobacterial infections: role of clarithromycin and azithromycin. Clin Ther 1997;19(4): 626-638.
18. Raad II, Vartivarian S, Khan A, Bodey GP: Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. Rev Infect Dis 1991;13:1120-1125.